A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07399067 · RECRUITING
Trial details
- NCT number
- NCT07399067
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-06
- Primary completion
- 2027-03-23
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.